Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
McKinsey
UBS
Moodys
Argus Health
Dow
Farmers Insurance
US Department of Justice

Generated: November 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 010971

« Back to Dashboard

NDA 010971 describes PMB 400, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the PMB 400 profile page.

The generic ingredient in PMB 400 is estrogens, conjugated; meprobamate. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated; meprobamate profile page.
Summary for 010971
Tradename:PMB 400
Applicant:Wyeth Ayerst
Ingredient:estrogens, conjugated; meprobamate
Patents:0

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.45MG;400MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 005

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.45MG;200MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 010971

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst PMB 400 estrogens, conjugated; meprobamate TABLET;ORAL 010971-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Wyeth Ayerst PMB 200 estrogens, conjugated; meprobamate TABLET;ORAL 010971-005 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
McKesson
Johnson and Johnson
Accenture
Baxter
Cerilliant
US Department of Justice
Fuji
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.